Measurements to accompany (pre-)clinical studies
ISAR Bioscience provides ELISA-based assay development according to good laboratory practice (GLP) on a fee-for-service basis, e. g. for the detection of drugs or other agents or for antibody detection in blood samples or other body liquids. The assays can be used for pharmacokinetic studies or antibody determinations in human or animal blood samples, e.g. during preclinical or clinical studies.
Similarly, detection and quantification of specific T lymphocytes and subsets is being carried out from patient blood samples according to strict quality management (QM) standards. These measurements are provided for diagnostic and therapeutic (pre-)clinical studies, e. g. to detect SARS-CoV2-specific T cells.